NOTE 4 - ACQUISITION OF THE CONSORTIUM: Schedule of business acquisition (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
ASSETS
Prepaids	$ 110,649		$ 110,649		$ 0
Total Assets	14,637,081		14,637,081		2,202,273
Liabilities
Related party payables	479,316		479,316		0
Total liabilities	1,814,488		1,814,488		362,883
Net liabilities assumed from issuance of shares in reverse merger			835,938	$ 0
Goodwill	$ 9,245,953		$ 9,245,953		$ 0
NewBridge shares prior to acquisition			3,695,604
Total shares outstanding following the acquisition	57,116,055		57,116,055
Total revenue	$ 10,000	$ 3,600	$ 17,200	$ 10,800
Consortium
ASSETS
Cash	8,886		8,886
Prepaids	207,704		207,704
Total Assets	216,590		216,590
Liabilities
Accounts payable and accrued liabilities	(246,150)		(246,150)
Convertible notes payable, net of discount	(34,723)		(34,723)
Derivative liability	(743,269)		(743,269)
Related party payables	(19,500)		(19,500)
Total liabilities	(1,043,642)		(1,043,642)
Net liabilities assumed from issuance of shares in reverse merger			(827,052)
Total consideration			8,418,901
Plus net liabilities assumed			827,052
Goodwill	$ 9,245,953		$ 9,245,953
Shares issued for the Consortium			31,000,000
Closing price of common stock on July 14, 2018	$ 0.85		$ 0.85
Total Value of the Company following the acquisition	$ 34,768,901		$ 34,768,901
Total Consideration (share price x 24.2%)			$ 8,418,901
Consortium | Pre acquisition
Liabilities
NewBridge shares prior to acquisition			9,904,589
Consortium | Post acquisition
Liabilities
Total shares outstanding following the acquisition	40,904,589		40,904,589
Consortium | Pro Forma
Liabilities
Total revenue			$ 36,200
Net loss allocable to common stockholders			$ (4,402,727)
Net loss per common share			$ (0.10)
Weighted-average number of shares outstanding			42,746,557